Dr. Wesley S. Moore, MD

Dr. Moore practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Moore's NPI, 1053335133, was assigned on July 26, 2006. Dr. Moore graduated from UCSF School of Medicine in 1959. Dr. Moore holds California license A19266.

Dr. Moore's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Moore's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Moore is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Gonda (Goldschmied) Vascular Center. Dmand AI also links Dr. Moore to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moore practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Moore's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Moore is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Moore's licenses on file in 2 states: California and Arizona.

Dmand AI lists aortic atherosclerois, arterial blot clot /embolism and peripheral vascular disease among the conditions Dr. Moore treats.

CMS data shows 227 Medicare services from Dr. Moore across 3 procedure codes in 2024, all of them office visits, for 169 Medicare patients. Medicare paid $19,877 for them. Every service was in an office.

CMS counts 169 Medicare patients who saw Dr. Moore in 2024. The largest group is 75 to 84, with 98 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moore's median patient age at 75, with 33% women.

In 2024, Dr. Moore wrote 223 Medicare Part D claims for 77 patients. 95% of them were for generic drugs. CMS names the drug for 192 of them, across 5 drugs with 11 or more claims each, at $4,870 in total drug cost. In 2023, CMS named 152 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Moore for performance year 2024, reported as part of a group. Dr. Moore accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Moore, published from 2011 to 2022. 2011 was the busiest year, with 2. The most frequent topics are Carotid Artery Diseases, Stents and Carotid Stenosis. Dr. Moore's most frequent co-authors are Thomas Brott, MD, Brajesh Kumar Lal, MD and Suhny Abbara, MD.

CMS Open Payments shows 106 general payments to Dr. Moore from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 85% of the total. Silk Road Medical, Inc. paid the most, $68,627.

Dmand AI lists 2 awards for Dr. Moore.

Dr. Moore graduated from UCSF School of Medicine in 1959. Dr. Moore is a member of ACS and SVS.

Dr. Moore is in network with 13 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.